Info: Zenodo’s user support line is staffed on regular business days between Dec 23 and Jan 5. Response times may be slightly longer than normal.

Published November 28, 2022 | Version v1
Report Open

Estimating the morbidity related environmental burden of disease due to exposure to PM2.5, NO2 and O3 in outdoor ambient air. ETC HE Report 2022/11.

  • 1. Federal Environment Agency/Umweltbundesamt (UBA)
  • 2. NILU - Norwegian Institute for Air Research, Kjeller, Norway
  • 3. EEA - European Environment Agency
  • 1. NILU - Norwegian Institute for Air Research
  • 2. INERIS
  • 3. Imperial College & EMRC
  • 4. SERC, WHO consultant, ECEH office Bonn

Description

This report provides an assessment of the impact of the ambient air pollutants PM2.5, NO2 and O3 on population health in Europe. It contains estimates of the morbidity related environmental burden of disease for ten risk-outcome pairs for Europe in 2019.

Scientific studies have increasingly shown that ambient air pollution is not only associated with mortality but also with the occurrence of a number of long and short-term health effects. This report provides an assessment of the impact of fine particulate matter (PM2.5), nitrogen dioxide (NO2) and ozone (O3) on population health. It contains estimates of the morbidity related environmental burden of disease for ten risk-outcome pairs for Europe in 2019.

Ten risk-outcome pairs were considered with different population age groups affected. For long-term PM2.5 exposure, the highest number of years lived with disability (YLDs) was calculated in relation to chronic obstructive pulmonary disease (175 731 YLDs) for people ≥25 years, and for NO2 in relation to diabetes mellitus (175 095 YLDs) for people ≥35 years. Short-term O3 exposure was estimated to result in 12 251 hospital admissions due to respiratory diseases in people ≥65 years.

The estimates are the first of its kind that are carried out for a wide range of morbidity health outcomes associated with different outdoor air pollutants in Europe, using a consistent methodology and data from European health databases.

Notes

OCP/EEA/CAS/21/005-ETC/HE Work programme 2022

Files

ETC HE Report 2022-11_Task_3_2_2_1_EBD_morbidity_FINAL_02-12-2022.pdf

Files (102.4 MB)

Name Size Download all
md5:d553669a2eb98b2a49c263b765de1c8a
10.0 MB Download
md5:e8a16317616a5bc6b6cfd0a339f69d62
9.9 MB Download
md5:526d1c424e0a7b2b88ee51675672daf5
10.0 MB Download
md5:d861f4fbdc8553b89906cdcf1e9d7c1a
9.9 MB Download
md5:6863a673968ccbcd5a086fed350792e5
10.0 MB Download
md5:1684b36421779860aa508de5dabf3e5f
9.9 MB Download
md5:d350eeeb3065255a4a3b14bbdfd44279
10.0 MB Download
md5:87d6063dbffa353d8623df1e6ed4d5c2
10.0 MB Download
md5:8891199744c2166f529fd4895e62330c
10.0 MB Download
md5:65c469c5ca8906c40b920a56f9b930b2
10.0 MB Download
md5:dfe19d0996103bd5f9ced93c0f69b42e
2.8 MB Preview Download